JPH11512400A5 - - Google Patents

Info

Publication number
JPH11512400A5
JPH11512400A5 JP1997511499A JP51149997A JPH11512400A5 JP H11512400 A5 JPH11512400 A5 JP H11512400A5 JP 1997511499 A JP1997511499 A JP 1997511499A JP 51149997 A JP51149997 A JP 51149997A JP H11512400 A5 JPH11512400 A5 JP H11512400A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997511499A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11512400A (ja
JP4101876B2 (ja
Filing date
Publication date
Priority claimed from AUPN5311A external-priority patent/AUPN531195A0/en
Application filed filed Critical
Publication of JPH11512400A publication Critical patent/JPH11512400A/ja
Publication of JPH11512400A5 publication Critical patent/JPH11512400A5/ja
Application granted granted Critical
Publication of JP4101876B2 publication Critical patent/JP4101876B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP51149997A 1995-09-11 1996-09-10 抗炎症活性を有する脂質抽出物 Expired - Lifetime JP4101876B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU5311 1983-08-10
AUPN5311A AUPN531195A0 (en) 1995-09-11 1995-09-11 Lipid extract having anti-inflamatory activity
PCT/AU1996/000564 WO1997009992A1 (en) 1995-09-11 1996-09-10 Lipid extract having anti-inflammatory activity

Publications (3)

Publication Number Publication Date
JPH11512400A JPH11512400A (ja) 1999-10-26
JPH11512400A5 true JPH11512400A5 (cg-RX-API-DMAC7.html) 2004-09-16
JP4101876B2 JP4101876B2 (ja) 2008-06-18

Family

ID=3789640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51149997A Expired - Lifetime JP4101876B2 (ja) 1995-09-11 1996-09-10 抗炎症活性を有する脂質抽出物

Country Status (12)

Country Link
US (2) US6083536A (cg-RX-API-DMAC7.html)
EP (1) EP0850068B1 (cg-RX-API-DMAC7.html)
JP (1) JP4101876B2 (cg-RX-API-DMAC7.html)
AT (1) ATE293984T1 (cg-RX-API-DMAC7.html)
AU (1) AUPN531195A0 (cg-RX-API-DMAC7.html)
CA (1) CA2231803C (cg-RX-API-DMAC7.html)
DE (1) DE69634666T2 (cg-RX-API-DMAC7.html)
DK (1) DK0850068T3 (cg-RX-API-DMAC7.html)
ES (1) ES2241001T3 (cg-RX-API-DMAC7.html)
PT (1) PT850068E (cg-RX-API-DMAC7.html)
WO (1) WO1997009992A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA967626B (cg-RX-API-DMAC7.html)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
WO1998054987A1 (en) * 1997-06-04 1998-12-10 Cellular Improvements Ltd Method and apparatus for disruption of biological material
SE9703085D0 (sv) * 1997-08-27 1997-08-27 Micro Active Protein In Sweden Anti-microbial composition
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US7220427B2 (en) 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
AUPP910699A0 (en) * 1999-03-10 1999-04-01 Pharmalink International Limited Inhibitor of lipoxygenase pathways
AU2005200953B2 (en) * 1999-03-22 2007-07-12 Mars, Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals and method of manufacturing same
US6596303B1 (en) * 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
US20020018787A1 (en) * 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
EP1408999B1 (en) * 1999-07-21 2008-03-12 Bomac Research Limited Compositions addressing inflammation and/or degenerative disorders
EP1212093B1 (en) * 1999-08-26 2004-07-07 Ganeden Biotech, Inc. Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications
AU2001293477B2 (en) * 2000-09-22 2006-05-18 Pharmalink International Limited Immunomodulatory preparation
AUPR030800A0 (en) * 2000-09-22 2000-10-12 Pharmalink International Limited Immunomodulatory preparation
US7519546B2 (en) * 2001-04-30 2009-04-14 General Electric Company Maintaining synchronization of information published to multiple subscribers
ES2288193T3 (es) 2001-07-27 2008-01-01 NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. Fosfolipidos naturales de origen marino que contienen flavonoides y fosfolipidos poliinsaturados y sus usos.
AUPS082102A0 (en) * 2002-03-01 2002-03-21 Women's And Children's Hospital Therapeutic properties of oils
AU2003222002A1 (en) * 2002-03-14 2003-09-29 Jackie H. Mcclung Pharmaceutically active compounds containing phosphorous defficient oil
DE20210182U1 (de) * 2002-07-01 2002-10-02 Bio-Innovation Development Ltd., Christchurch Wirkstoffzusammensetzung aus Bestandteilen der Grünlippenmuschel (perna canaliculus) und zusätzlichen Omega-3-Fettsäuren
MXPA05009894A (es) * 2003-03-14 2006-12-14 Foodscience Corp Metodos para el tratamiento de cancer usando componente(s) de perna canaliculus y extractos de perna canaliculus.
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7052715B2 (en) * 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
WO2005073354A1 (en) * 2004-01-30 2005-08-11 Bionovate Limited Solvent extraction of lipids such as essential fatty acids
GB0411166D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Treatment for asthma and arthritis
GB0411165D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Hyaluronic acid containing pharmaceutical or veterinary compounds
US20060039992A1 (en) * 2004-06-02 2006-02-23 Miller Bruce A Jr Novel compositions and methods utilizing green-lipped mussel and fatty acids
WO2006052150A1 (en) * 2004-11-15 2006-05-18 University Of Otago Mussel extract composition with enhanced anti-inflammatory activity
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
NZ563125A (en) * 2005-06-03 2009-11-27 Mcfarlane Marketing Aust Pty L Lipid extract of mussels and method for preparation thereof
NZ547429A (en) * 2006-05-24 2009-09-25 Ind Res Ltd Extraction of highly unsaturated lipids with liquid dimethyl ether
WO2008017903A1 (en) 2006-08-08 2008-02-14 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
EP2041068B1 (en) 2006-07-18 2017-01-25 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate
PL2046727T3 (pl) 2006-07-25 2014-08-29 Techfields Biochem Co Ltd Dodatnio naładowane rozpuszczalne w wodzie proleki diklofenaku o bardzo szybkim stopniu przenikania przez skórę
CN101506168B (zh) 2006-09-03 2014-12-10 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药
CN101506143B (zh) 2006-09-03 2013-06-05 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的对乙酰氨基酚及其相关化合物的前药
JP5215858B2 (ja) * 2006-09-22 2013-06-19 株式会社ハイマート 抗血管新生作用を有する抽出物とレシチンを含有する抗血管新生組成物
JP5378219B2 (ja) * 2006-10-02 2013-12-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
EP2084165B1 (en) 2006-10-11 2013-06-12 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
NZ552238A (en) * 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
US8337916B2 (en) * 2007-06-01 2012-12-25 Laila Nutraceuticals Use of Aphanamixis polystacha extracts or fractions against 5-lipoxygenase mediated diseases
MX377501B (es) * 2007-06-04 2025-03-10 Techfields Inc Profarmacos de nsaias con el piel y membranas con indices de penetracion muy altos y nuevos usos medicinales.
MX340963B (es) * 2008-04-28 2016-07-29 Vermont Italia Srl Formulacion farmaceutica que contiene palmitoil etanolamida y estearoil etanolamida.
CN108191846B (zh) 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
JP5313064B2 (ja) * 2009-07-03 2013-10-09 株式会社ノエビア 中性脂肪蓄積促進剤、豊胸剤
CA3189252A1 (en) 2012-01-18 2013-11-21 Techfields Pharma Co., Ltd. High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
US20150374835A1 (en) 2012-12-31 2015-12-31 Jrx Biotechnology, Inc. Liquid topical pharmaceutical nano-emulsion formulations
JP6176655B2 (ja) * 2013-07-02 2017-08-09 御木本製薬株式会社 マトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤、老化防止用皮膚外用剤、シワ防止用皮膚外用剤、慢性関節リウマチ及び他の疾患の治療又は予防剤
EP3326639B1 (en) * 2015-07-20 2023-11-01 Jiangyin Bengt I. Samuelsson Institute of Life Science Co., Ltd. Mussel adhesive protein product and applications thereof in suppression of skin inflammations
CN108024914A (zh) 2015-09-17 2018-05-11 Jrx生物技术有限公司 改善皮肤的水合作用或润湿作用的方法
CN110213971A (zh) * 2016-12-20 2019-09-06 三福有限公司 加工贝类的方法和所得的组合物
EP3720294A1 (en) * 2017-12-04 2020-10-14 Rimfrost Technologies AS Method for producing a protein phospholipid complex from a crustacean catch
AR117943A1 (es) * 2017-12-22 2021-09-08 Pharmalink International Ltd Combinaciones de lípidos
JP2023511574A (ja) * 2020-01-21 2023-03-20 リントベルズ・リミテッド 相乗作用性組成物
CN113041263B (zh) * 2021-03-15 2023-07-25 青岛大学 一种贻贝功能性脂质在制备治疗2型糖尿病产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965855D1 (en) * 1978-09-25 1983-08-18 Farlane Stuart John Mc Pharmaceutical preparations containing a mollusc extract
US4801453A (en) 1984-05-01 1989-01-31 James M. Broadbent Stabilized mussel extract
AUPM740594A0 (en) 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AU3156595A (en) * 1994-08-11 1996-03-07 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity

Similar Documents

Publication Publication Date Title
JP2000500445A5 (cg-RX-API-DMAC7.html)
JP2000500033A5 (cg-RX-API-DMAC7.html)
JP2000500228A5 (cg-RX-API-DMAC7.html)
JP2000500440A5 (cg-RX-API-DMAC7.html)
JP2000500327A5 (cg-RX-API-DMAC7.html)
JP2000500145A5 (cg-RX-API-DMAC7.html)
JP2000500155A5 (cg-RX-API-DMAC7.html)
JP2000500406A5 (cg-RX-API-DMAC7.html)
JP2000500361A5 (cg-RX-API-DMAC7.html)
JP2000500115A5 (cg-RX-API-DMAC7.html)
JP2000500322A5 (cg-RX-API-DMAC7.html)
JP2000500258A5 (cg-RX-API-DMAC7.html)
JP2000500342A5 (cg-RX-API-DMAC7.html)
JP2000500192A5 (cg-RX-API-DMAC7.html)
JP2000500112A5 (cg-RX-API-DMAC7.html)
JP2000500226A5 (cg-RX-API-DMAC7.html)
JP2000500051A5 (cg-RX-API-DMAC7.html)
JP2000500397A5 (cg-RX-API-DMAC7.html)
JP2000500407A5 (cg-RX-API-DMAC7.html)
JP2000500019A5 (cg-RX-API-DMAC7.html)
JP2000500166A5 (cg-RX-API-DMAC7.html)
JP2000500125A5 (cg-RX-API-DMAC7.html)
JP2000500044A5 (cg-RX-API-DMAC7.html)
JP2000500346A5 (cg-RX-API-DMAC7.html)
JP2000500257A5 (cg-RX-API-DMAC7.html)